Beardsley Robert A
SEC insider (Form 3/4/5 filer). CIK 0001310845. Director at Arbutus Biopharma Corp (ABUS). 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in WARMINSTER, PA.
Companies Beardsley Robert A has filed insider reports for
- Arbutus Biopharma Corp (ABUS): Director
Beardsley Robert A
CIK: 0001310845
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Arbutus Biopharma Corp
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Oct 1, 2026ABUS
Arbutus Biopharma Corp
DispositionDirect17.9K shares at avg. $5.00$90K - Sep 18, 2026ABUS
Arbutus Biopharma Corp
ExerciseDirect52.5K shares at avg. $3.20$168K - Sep 18, 2026ABUS
Arbutus Biopharma Corp
ExerciseDirect78.8K shares at avg. $4.24$334K - Sep 18, 2026ABUS
Arbutus Biopharma Corp
Tax PaymentDirect99.1K shares at avg. $5.07$502K - Jun 8, 2026ABUS
Arbutus Biopharma Corp
AwardDirectStock Option (Right to Buy)
78.8K shares- - Mar 18, 2025ABUS
Arbutus Biopharma Corp
AwardDirectStock Option (Right to Buy)
157.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | ABUS Arbutus Biopharma Corp | Disposition | 17,948 | $5.00 | $89,740 | Direct |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | Exercise | 52,533 | $3.20 | $168,106 | Direct |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | Exercise | 78,800 | $4.24 | $334,112 | Direct |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | Tax Payment | 99,057 | $5.07 | $502,219 | Direct |
| Jun 8, 2026 | ABUS Arbutus Biopharma Corp | Award Stock Option (Right to Buy) | 78,800 | - | - | Direct |
| Mar 18, 2025 | ABUS Arbutus Biopharma Corp | Award Stock Option (Right to Buy) | 157,600 | - | - | Direct |
1-6 of 6 transactions